Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders - PubMed
- ️Sat Jan 01 2022
doi: 10.3389/fonc.2022.886404. eCollection 2022.
Michele Tomasoni 2 , Cristina Gurizzan 1 , Chiara Magri 1 , Mattia Facchetti 3 , Simonetta Battocchio 3 , Chiara Romani 4 , Marco Ravanelli 5 , Arianna Oberti 3 , Anna Bozzola 3 , Elena Bardellini 6 , Alberto Paderno 2 , Davide Mattavelli 2 , Davide Lombardi 2 , Alberto Grammatica 2 , Alberto Deganello 2 , Fabio Facchetti 3 , Stefano Calza 7 8 , Alessandra Majorana 6 , Cesare Piazza 2 , Paolo Bossi 1
Affiliations
- PMID: 35530364
- PMCID: PMC9069132
- DOI: 10.3389/fonc.2022.886404
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders
Luigi Lorini et al. Front Oncol. 2022.
Abstract
Background: Oral potentially malignant disorders (OPMDs) represent a heterogeneous set of different histological lesions, characterized by the capacity to transform in oral squamous cell carcinoma (OSCC). Despite optimal surgical treatment, approximately 20%-30% of OPMDs may evolve into OSCC. No clear clinical/histological factors are able to identify OPMDs at higher risk of malignant transformation.
Materials and methods: We considered surgically treated patients with a diagnosis of OPMDs, enrolled from 1996 to 2019 at ASST Spedali Civili of Brescia without a diagnosis of OSCC within the previous 2 years. Clinical and histological characteristics were recorded. Outcomes of interest were recurrence-free survival (RFS), defined as the time from surgery for primary OPMD to any relapse of OPMD or malignant transformation, whichever occurred first, and carcinoma-free survival (CFS), defined as the time from surgery for OPMD to malignant transformation.
Results: We retrospectively reviewed 106 OPMDs cases. Median age at first diagnosis was 64 years old (IQR = 18.75); female patients comprise 51.9% of the cases. During a median follow-up of 30.5 months (IQR = 44), in 23.5% of patients, malignant transformation occurred. RFS at 1, 5, and 10 years was 92.4%, 60.9%, and 43.2%, respectively. Female sex and history of previous OSCC were independent risk factors for RFS. CFS at 1, 5, and 10 years of follow-up was 97.1%, 75.9%, and 64.4%, respectively. Previous OSCC was an independent risk factor for CFS.
Conclusions: In this large series of OPMDs, only previous diagnosis of OSCC was a prognostic factor for further OSCC occurrence. Given the lack of additional clinical/pathological prognostic factors, we advocate further studies into molecular characterization of OPMDs to better stratify the risk of malignant transformation.
Keywords: head and neck squamous cell carcinoma (HNSCC); oral carcinoma risk factors; oral potentially malignant disease; oral squamous cell carcinoma (OSCC); prevention of malignant transformation.
Copyright © 2022 Lorini, Tomasoni, Gurizzan, Magri, Facchetti, Battocchio, Romani, Ravanelli, Oberti, Bozzola, Bardellini, Paderno, Mattavelli, Lombardi, Grammatica, Deganello, Facchetti, Calza, Majorana, Piazza and Bossi.
Conflict of interest statement
PB declares advisory board participation or conference honoraria from Merck, Sanofi-Regeneron, Merck Sharp & Dohme, Sun Pharma, Angelini, Molteni, Bristol-Myers Squibb, GSK, and Nestlè. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

(A) Recurrence-free survival, (B) carcinoma-free survival of the whole population, (C) carcinoma-free survival of the population without a history of previous OSCC. Survival curves are reported with relative tables of patients at risk.

Recurrence-free survival curves with relative tables of patients at risk according to (A) sex and (B) history of previous OSCC.

Carcinoma-free survival curves with relative tables of patients (whole population) at risk according to (A) sex and (B) history of previous OSCC.
Similar articles
-
Aamir R, Rauf F, Iqbal F, Yousuf S, Rehman A, Sheikh AK, Muhammad S. Aamir R, et al. Appl Immunohistochem Mol Morphol. 2024 Mar 1;32(3):157-162. doi: 10.1097/PAI.0000000000001185. Epub 2024 Jan 25. Appl Immunohistochem Mol Morphol. 2024. PMID: 38268382
-
Zhang X, Yang M, Liu Y, Liu H, Yang J, Luo J, Zhou H. Zhang X, et al. Arch Oral Biol. 2021 Sep;129:105203. doi: 10.1016/j.archoralbio.2021.105203. Epub 2021 Jun 30. Arch Oral Biol. 2021. PMID: 34252587
-
Chen L, Luo T, Yang J, Wang K, Liu S, Wei Y, Liu H, Xu J, Zheng J, Zeng Y. Chen L, et al. J Oral Pathol Med. 2021 Feb;50(2):165-174. doi: 10.1111/jop.13115. Epub 2020 Oct 29. J Oral Pathol Med. 2021. PMID: 33064859
-
Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies.
Lorini L, Bescós Atín C, Thavaraj S, Müller-Richter U, Alberola Ferranti M, Pamias Romero J, Sáez Barba M, de Pablo García-Cuenca A, Braña García I, Bossi P, Nuciforo P, Simonetti S. Lorini L, et al. Cancers (Basel). 2021 Jul 23;13(15):3696. doi: 10.3390/cancers13153696. Cancers (Basel). 2021. PMID: 34359597 Free PMC article. Review.
-
Molecular diagnostics in oral cancer and oral potentially malignant disorders-A clinician's guide.
Yap T, Celentano A, Seers C, McCullough MJ, Farah CS. Yap T, et al. J Oral Pathol Med. 2020 Jan;49(1):1-8. doi: 10.1111/jop.12920. Epub 2019 Aug 3. J Oral Pathol Med. 2020. PMID: 31309636 Review.
Cited by
-
Hassan MA, Weyers BW, Bec J, Fereidouni F, Qi J, Gui D, Bewley AF, Abouyared M, Farwell DG, Birkeland AC, Marcu L. Hassan MA, et al. IEEE Trans Biomed Eng. 2023 Oct;70(10):2863-2873. doi: 10.1109/TBME.2023.3266678. Epub 2023 Sep 27. IEEE Trans Biomed Eng. 2023. PMID: 37043314 Free PMC article.
-
Recurrence in Oral Leukoplakia: A Systematic Review and Meta-analysis.
Bhattarai BP, Singh AK, Singh RP, Chaulagain R, Søland TM, Hasséus B, Sapkota D. Bhattarai BP, et al. J Dent Res. 2024 Oct;103(11):1066-1075. doi: 10.1177/00220345241266519. Epub 2024 Sep 18. J Dent Res. 2024. PMID: 39290142